Showing results 2725 to 2744 of 3067
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2004 | The neuropathology of melioidosis: two cases and a review of the literature | Koszyca, B.; Currie, B.; Blumbergs, P. |
| 2014 | The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96-110 | Corrigan, F.; Thornton, E.; Roisman, L.; Leonard, A.; Vink, R.; Blumbergs, P.; Van Den Heuvel, C.; Cappai, R. |
| 2011 | The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains | Corrigan, F.; Pham, C.; Vink, R.; Blumbergs, P.; Masters, C.; Van Den Heuvel, C.; Cappai, R. |
| 2016 | The neuroprotective properties of the amyloid precursor protein following traumatic brain injury | Plummer, S.; Van Den Heuvel, C.; Thornton, E.; Corrigan, F.; Cappai, R. |
| 2012 | The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions | Santerre, J.; Nunes, E.; Kovner, R.; Leser, C.; Randall, P.; Collins-Praino, L.; Cruz, L.; Correa, M.; Baqi, Y.; Muller, C.; Salamone, J. |
| 2012 | The novel adenosine A₂A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade | Collins-Praino, L.; Sager, T.; Sams, A.; Pennarola, A.; Port, R.; Shahriari, M.; Salamone, J. |
| 2021 | The nuclear transporter importin 13 is critical for cell survival during embryonic stem cell differentiation | Fatima, S.; Wagstaff, K.M.; Lim, S.M.; Polo, J.M.; Young, J.C.; Jans, D.A. |
| 2011 | The Optics of bruising | Randeberg, L.; Skallerud, B.; Langlois, N.; Haugen, O.; Svaasand, L.; Welch Martin, A.; van Gemert, J. |
| 2001 | The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis | Haynes, D.; Crotti, T.; Potter, A.; Loric, M.; Atkins, G.; Howie, D.; Findlay, D. |
| 2010 | The outcome of scaphoid excision and four-corner arthrodesis for advanced carpal collapse at a minimum of ten years | Bain, G.; Watts, A. |
| 2004 | The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats | Cernak, I.; Vink, R.; Zapple, D.; Cruz, M.; Ahmed, F.; Chang, T.; Fricke, S.; Faden, A. |
| 1997 | The pathologic effects of intrathecal betamethasone | Latham, J.; Fraser, R.; Moore, R.; Blumbergs, P.; Bogduk, N. |
| 1996 | The pathological approach to sudden infant death - Concensus or confusion? | Byard, R.; Becker, L.; Berry, P.; Campbell, P.; Fitzgerald, K.; Hilton, J.; Krous, H.; Rognum, T. |
| 2006 | The pathological features and circumstances of death of lethal crush/traumatic asphyxia in adults - A 25-year study | Byard, R.; Wick, R.; Simpson, E.; Gilbert, J. |
| 2014 | The pathological features of Wernicke encephalopathy | Olds, K.; Langlois, N.E.I.; Blumbergs, P.; Byard, R.W. |
| 2000 | The permeability of the microvascalature of the perfused rat testis to small hydrophilic substances | Bustamante, J.; Setchell, B. |
| 2013 | The pharmacokinetics and pharmacodynamics of single dose (R)- and (S)-warfarin administered separately and together: relationship to VKORC1 genotype | Maddison, J.; Somogyi, A.; Jensen, B.; James, H.; Gentgall, M.; Rolan, P. |
| 2002 | The pharmacokinetics pharmacodynamics safety and tolerability of NN2211 a new long-acting GLP-1 derivative in healthy men | Agerso, H.; Jensen, L.; Elbrond, B.; Rolan, P.; Zdravkovic, M. |
| 2008 | The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men | Rolan, P.; Sargentini-Maier, M.; Pigeolet, E.; Stockis, A. |
| 2007 | The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males | Sargentini-Maier, M.; Rolan, P.; Connell, J.; Tytgat, D.; Jacobs, T.; Pigeolet, E.; Riethuisen, J.; Stockis, A. |